Alnylam Pharmaceuticals, Inc. (ALNY) vs GE HealthCare Technologies Inc. (GEHC)
ALNY leads on 7 of 13 compared metrics, though GEHC is the cheaper stock.
A side-by-side comparison of Alnylam Pharmaceuticals, Inc. and GE HealthCare Technologies Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 15, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
ALNY
Alnylam Pharmaceuticals, Inc.
$280.59HealthcareDelayed quote: Jul 15, 2026, 11:45 AM EDT
GEHC
GE HealthCare Technologies Inc.
$63.26HealthcareDelayed quote: Jul 15, 2026, 11:45 AM EDT
Total return — ALNY vs GEHC
growth of $100 · dividends reinvested · last 4yALNY +18.7%GEHC +3.3%ALNY compounded faster
ALNY GEHC
ALNY vs GEHC: by the numbers
- •ALNY is the larger company ($37.46B vs $28.78B market cap).
- •GEHC trades at the lower earnings multiple (18.86 vs 66.81 P/E).
- •ALNY converts more revenue to profit (13.46% vs 7.54% net margin).
- •ALNY grew revenue faster over the past five years (49.67% vs 3.74% CAGR).
- •GEHC pays a dividend (0.23% yield) while ALNY does not currently pay one.
Which is better, ALNY or GEHC?
Metric tally: ALNY 7 · GEHC 6It depends on what you're optimizing for:
ValueGEHC(lower P/E)
GrowthALNY(faster 5Y revenue CAGR)
QualityALNY(higher ROIC)
Metrics side by side
Valuation
| Metric | ALNY | GEHC |
|---|---|---|
| P/E ratio | 66.81 | 18.86● |
| Forward P/E | 37.91 | 12.63● |
| P/S ratio | 9.07 | 1.41● |
| P/B ratio | 36.15 | 2.64● |
| PEG ratio | — | 4.14 |
| EV / EBITDA | 47.64 | 10.47● |
| FCF yield | 1.65% | 5.39%● |
Profitability
| Metric | ALNY | GEHC |
|---|---|---|
| Gross margin | 80.89%● | 42.55% |
| Operating margin | 17.54%● | 12.46% |
| Net margin | 13.46%● | 7.54% |
| ROE | 53.68%● | 14.11% |
| ROIC | 13.74%● | 8.84% |
Dividends
| Metric | ALNY | GEHC |
|---|---|---|
| Dividend yield | — | 0.23% |
| Payout ratio | — | 3.07% |
Growth (annualized)
| Metric | ALNY | GEHC |
|---|---|---|
| Revenue CAGR (5Y) | 49.67%● | 3.74% |
| EPS CAGR (5Y) | — | 0.67% |
| FCF CAGR (5Y) | 14.35%● | 1.07% |
| Total return CAGR (5Y) | 10.55% | — |
Frequently asked
- Which is better, ALNY or GEHC?
- It depends on your goal. value: GEHC (lower P/E); growth: ALNY (faster 5Y revenue CAGR); quality: ALNY (higher ROIC). Across all compared metrics, ALNY leads 7 to 6.
- Is ALNY or GEHC cheaper?
- On trailing earnings, GEHC is cheaper: ALNY trades at a 66.81 P/E and GEHC at 18.86.
- Which has grown faster, ALNY or GEHC?
- Over the past five years, ALNY grew revenue faster — ALNY at a 49.67% CAGR versus GEHC at 3.74%.
- Does ALNY or GEHC pay a bigger dividend?
- GEHC pays a dividend (0.23% yield) while ALNY does not currently pay one.
- Is ALNY or GEHC more profitable?
- ALNY runs the higher net margin — ALNY at 13.46% versus GEHC at 7.54%.
Go deeper
Dig into the metrics
Alnylam Pharmaceuticals P/E ratioGE HealthCare Technologies P/E ratioAlnylam Pharmaceuticals dividend yieldGE HealthCare Technologies dividend yieldAlnylam Pharmaceuticals ROEGE HealthCare Technologies ROEAlnylam Pharmaceuticals operating marginGE HealthCare Technologies operating marginAlnylam Pharmaceuticals revenue growthGE HealthCare Technologies revenue growthAlnylam Pharmaceuticals free cash flowGE HealthCare Technologies free cash flow
Alnylam Pharmaceuticals & GE HealthCare Technologies appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 15, 2026.